WCM
RDY icon

WealthBridge Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

WealthBridge Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-625
Closed -$5K – 688
2019
Q1 		$5K Buy
+625
New +$4.75K ﹤0.01% 690

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

WealthBridge Capital Management's RDY Position: Q2 2019 in Review

WealthBridge Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2019, closing a stake of 625 shares — an estimated $5K sold.

WealthBridge Capital Management first reported a position in RDY in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 150 funds tracked by Wall St. Rank hold RDY as of Q2 2019.

  • WealthBridge Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2019 after selling out during the quarter.
  • WealthBridge Capital Management sold 625 Dr. Reddy's Laboratories shares in Q2 2019, an estimated $5K.
  • WealthBridge Capital Management first reported a position in Dr. Reddy's Laboratories in Q1 2019 and held it in 1 quarter.
  • WealthBridge Capital Management's Dr. Reddy's Laboratories position peaked at $5K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2019.

Based on WealthBridge Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.